David Redfern
Vermogen: 6 M $ op 30-06-2026
Vermogen: 6 M $ op 30-06-2026
David Simon Redfern currently works at ViiV Healthcare Ltd., as Chairman from 2011, Human Genome Sciences, Inc., as Director from 2012, Aspen Pharmacare Holdings Ltd., as Non-Executive Director from 2015, Haleon UK Holdings Ltd., as Director, and GSK Plc, as President-Corporate Development.
Mr. Redfern also formerly worked at Haleon UK Holdings (No.2) Ltd., as Director from 2019 to 2022, GlaxoSmithKline South Africa (Pty) Ltd., as Finance Director-European Business, and PricewaterhouseCoopers Services Ltd., as Principal.
Mr. Redfern received his undergraduate degree from the University of Bristol.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GSK PLC 0,01% | 13-07-2026 | 225.304 ( 0,01% ) | 6 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01-05-2008 |
| ASPEN PHARMACARE HOLDINGS LIMITED | Directeur/Bestuurslid | 01-02-2015 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Voorzitter | 01-04-2011 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Directeur/Bestuurslid | 30-07-2012 |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Bestuurslid | 18-07-2022 |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Corporate Officer/Principal | - |
PricewaterhouseCoopers Services Ltd.
PricewaterhouseCoopers Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, bookkeeping, business consulting and tax advisory services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Aspen Pharmacare Holdings Ltd.
Aspen Pharmacare Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals products | Health Technology |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Health Technology |
PricewaterhouseCoopers Services Ltd.
PricewaterhouseCoopers Services Ltd. Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, bookkeeping, business consulting and tax advisory services | Commercial Services |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
GlaxoSmithKline Consumer Healthcare Holdings Ltd.
GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Haleon UK Holdings (No.2) Ltd.
Haleon UK Holdings (No.2) Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau